Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,104 | -7,087 | -5,805 | -4,215 | -26,067 |
| Depreciation Amortization | 288 | 221 | 155 | 90 | 380 |
| Accounts receivable | 28 | -2,109 | -505 | 1,293 | 726 |
| Accounts payable and accrued liabilities | -867 | -233 | -1,301 | -190 | -34 |
| Other Working Capital | -3,798 | -4,971 | -3,591 | -484 | -2,347 |
| Other Operating Activity | 6,170 | 7,432 | 5,731 | 284 | 6,943 |
| Operating Cash Flow | $-8,284 | $-6,747 | $-5,315 | $-3,222 | $-20,399 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -83 | -79 | -67 | -3 | -582 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | 300 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 300 |
| Investing Cash Flow | $-83 | $-79 | $-67 | $-3 | $-282 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,000 |
| Debt Repayment | -10,959 | -12,472 | -12,194 | -12,188 | N/A |
| Common Stock Issued | 8 | N/A | N/A | N/A | 6,610 |
| Dividend Paid | -163 | -122 | -81 | -41 | -163 |
| Other Financing Activity | 6,900 | 6,900 | 6,900 | 0 | 0 |
| Financing Cash Flow | $-4,213 | $-5,694 | $-5,375 | $-12,228 | $9,447 |
| Exchange Rate Effect | -65 | -60 | -58 | -25 | 50 |
| Beginning Cash Position | 19,782 | 19,782 | 19,782 | 19,782 | 30,966 |
| End Cash Position | 7,137 | 7,202 | 8,967 | 4,303 | 19,782 |
| Net Cash Flow | $-12,645 | $-12,579 | $-10,815 | $-15,479 | $-11,184 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,284 | -6,747 | -5,315 | -3,222 | -20,399 |
| Capital Expenditure | -83 | -79 | -67 | -3 | -582 |
| Free Cash Flow | -8,367 | -6,826 | -5,382 | -3,226 | -20,982 |